SecSonar.com

Matinas BioPharma Holdings, Inc. (MTNB)

Matinas BioPharma Holdings, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Matinas BioPharma Holdings, Inc. (MTNB) is a Biotechnology company based in US with a market capitalization of $4.5M. Free cash flow was negative at -$7M. This page tracks MTNB's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 3 employees · IPO Jul 21, 2014

Valuation

Valuation & price

$0.56 · as of May 17, 2026 · -76.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.93

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.36$1.43$0.50Jul 25Dec 25Jul 26Jul 7, 25$0.92Jul 9, 25$0.99Jul 11, 25$1.03Jul 15, 25$0.99Jul 17, 25$0.96Jul 21, 25$0.96Jul 23, 25$0.95Jul 25, 25$0.93Jul 29, 25$0.88Jul 31, 25$0.88Aug 4, 25$0.96Aug 6, 25$0.90Aug 11, 25$1.60Aug 13, 25$1.56Aug 15, 25$2.36Aug 19, 25$1.70Aug 21, 25$1.74Aug 25, 25$2.15Aug 27, 25$1.98Aug 29, 25$1.82Sep 3, 25$1.82Sep 5, 25$1.72Sep 9, 25$1.64Sep 11, 25$1.80Sep 16, 25$1.70Sep 18, 25$1.73Sep 22, 25$2.06Sep 24, 25$1.92Sep 26, 25$1.90Sep 30, 25$1.89Oct 2, 25$1.93Oct 6, 25$1.90Oct 8, 25$1.87Oct 10, 25$1.71Oct 14, 25$1.90Oct 16, 25$1.71Oct 21, 25$1.65Oct 23, 25$1.58Oct 27, 25$1.53Oct 29, 25$1.34Oct 31, 25$1.38Nov 4, 25$1.27Nov 6, 25$1.22Nov 10, 25$1.17Nov 12, 25$1.27Nov 14, 25$1.22Nov 18, 25$1.18Nov 20, 25$0.84Nov 25, 25$0.72Nov 28, 25$0.75Dec 2, 25$0.81Dec 4, 25$0.75Dec 8, 25$0.89Dec 10, 25$0.79Dec 12, 25$0.79Dec 16, 25$0.74Dec 18, 25$0.78Dec 22, 25$0.75Dec 24, 25$0.69Dec 29, 25$0.60Jan 2, 26$0.62Jan 6, 26$0.60Jan 8, 26$0.73Jan 12, 26$0.65Jan 14, 26$0.71Jan 16, 26$0.69Jan 21, 26$0.59Jan 23, 26$0.72Jan 27, 26$0.72Jan 29, 26$0.67Feb 2, 26$0.60Feb 4, 26$0.63Feb 9, 26$0.63Feb 11, 26$0.62Feb 13, 26$0.59Feb 18, 26$0.62Feb 20, 26$0.61Feb 24, 26$0.63Feb 26, 26$0.60Mar 2, 26$0.62Mar 4, 26$0.60Mar 6, 26$0.60Mar 10, 26$0.60Mar 12, 26$0.64Mar 17, 26$0.64Mar 19, 26$0.59Mar 23, 26$0.64Mar 25, 26$0.57Mar 27, 26$0.56Mar 31, 26$0.50Apr 2, 26$0.55Apr 7, 26$0.50Apr 9, 26$0.50Apr 13, 26$0.50Apr 15, 26$0.53Apr 17, 26$0.50Apr 22, 26$0.56Apr 24, 26$0.61Apr 28, 26$0.60Apr 30, 26$0.65May 4, 26$0.67May 6, 26$0.68May 8, 26$0.64May 12, 26$0.59May 14, 26$0.57May 18, 26$0.54May 20, 26$0.64May 22, 26$0.70May 28, 26$0.79Jun 1, 26$0.87Jun 3, 26$0.78Jun 5, 26$0.79Jun 9, 26$0.80Jun 11, 26$0.81Jun 15, 26$0.75Jun 17, 26$0.71Jun 22, 26$0.63Jun 24, 26$0.65Jun 26, 26$0.64Jul 2, 26$0.63
$0.4952-week range$2.36
Loading valuation history…

Fundamentals

Key fundamentals

$4.5M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$7M

Free cash flow (USD)

-$2.6M

Net debt

Net cash position

12.5%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$0.00FY 2017$149.7KFY 2018$119.8KFY 2019$89.8KFY 2020$158.3KFY 2021$33.0KFY 2022$3.2MFY 2023$1.1MFY 2024$0.00FY 2025$0.00
$0$0

Free cash flow by year

2016 → 2025

FY 2016$-6.1MFY 2017$-12.4MFY 2018$-10.9MFY 2019$-14.5MFY 2020$-17.4MFY 2021$-15.5MFY 2022$-20.0MFY 2023$-15.5MFY 2024$-15.9MFY 2025$-7.0M
-$6.1M-$7M

Gross margin by year

2021 → 2023

FY 2021-44090.9%FY 2022-423.1%FY 2023100.0%
-44090.9%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 8, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventDelisting NoticeJun 26, 2026Filing
  • FinancingSecurities RegistrationJun 16, 2026Filing
  • Quarterly report10-Q FiledMay 8, 2026Filing
  • 8-K eventDelisting NoticeApr 3, 2026Filing

Questions

Frequently asked questions

What is Matinas BioPharma Holdings, Inc.'s market cap?

Matinas BioPharma Holdings, Inc. (MTNB) has a market capitalization of $4.5M.

What is MTNB's P/E ratio?

A meaningful P/E ratio is not available for MTNB — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is MTNB's price-to-book (P/B) ratio?

MTNB trades at 0.93 times book value per share.

Are insiders buying MTNB stock?

SEC Form 4 filings show no open-market insider buys at Matinas BioPharma Holdings, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

BRTX

BioRestorative Therapies, Inc.

$4.6M

HCWB

HCW Biologics Inc.

$4.3M

ADXN

Addex Therapeutics Ltd

$5M

CLGN

CollPlant Biotechnologies Ltd.

$5M

PULM

Pulmatrix, Inc.

$5M

BCAB

BioAtla, Inc.

$5M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.